These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24022401)

  • 1. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy.
    Ishikawa K; Yoshida S; Nakao S; Nakama T; Kita T; Asato R; Sassa Y; Arita R; Miyazaki M; Enaida H; Oshima Y; Murakami N; Niiro H; Ono J; Matsuda A; Goto Y; Akashi K; Izuhara K; Kudo A; Kono T; Hafezi-Moghadam A; Ishibashi T
    FASEB J; 2014 Jan; 28(1):131-42. PubMed ID: 24022401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
    Ishikawa K
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid suppresses the adhesion and migration of human retinal pigment epithelial cells.
    Du YH; Hirooka K; Miyamoto O; Bao YQ; Zhang B; An JB; Ma JX
    Exp Eye Res; 2013 Apr; 109():22-30. PubMed ID: 23428742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
    Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
    Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
    BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
    Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
    Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
    Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
    Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin in vitreoretinal diseases.
    Yoshida S; Nakama T; Ishikawa K; Nakao S; Sonoda KH; Ishibashi T
    Cell Mol Life Sci; 2017 Dec; 74(23):4329-4337. PubMed ID: 28913545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
    Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
    Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.
    Kita T; Hata Y; Arita R; Kawahara S; Miura M; Nakao S; Mochizuki Y; Enaida H; Goto Y; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17504-9. PubMed ID: 18952846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
    Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
    Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-1 influences migration of retinal pigment epithelial cells.
    Alge CS; Priglinger SG; Kook D; Schmid H; Haritoglou C; Welge-Lussen U; Kampik A
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):415-26. PubMed ID: 16384992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
    Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
    Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease pathways in proliferative vitreoretinopathy: an ongoing challenge.
    Tosi GM; Marigliani D; Romeo N; Toti P
    J Cell Physiol; 2014 Nov; 229(11):1577-83. PubMed ID: 24604697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin-alpha5 mediates epidermal growth factor-induced retinal pigment epithelial cell proliferation and migration.
    Chen Z; Chen CZ; Gong WR; Li JP; Xing YQ
    Pathobiology; 2010; 77(2):88-95. PubMed ID: 20332668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.